Robey RW - Search Results

1

HG-829 is a potent noncompetitive inhibitor of the ATP-binding cassette multidrug resistance transporter ABCB1.

Caceres G, Robey RW, Sokol L, McGraw KL, Clark J, Lawrence NJ, Sebti SM, Wiese M, List AF. Caceres G, et al. Among authors: robey rw. Cancer Res. 2012 Aug 15;72(16):4204-13. doi: 10.1158/0008-5472.CAN-12-0743. Epub 2012 Jul 3. Cancer Res. 2012. PMID: 22761337 Free PMC article.

2

Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes.

Miyake K, Mickley L, Litman T, Zhan Z, Robey R, Cristensen B, Brangi M, Greenberger L, Dean M, Fojo T, Bates SE. Miyake K, et al. Cancer Res. 1999 Jan 1;59(1):8-13. Cancer Res. 1999. PMID: 9892175

3

Camptothecin resistance: role of the ATP-binding cassette (ABC), mitoxantrone-resistance half-transporter (MXR), and potential for glucuronidation in MXR-expressing cells.

Brangi M, Litman T, Ciotti M, Nishiyama K, Kohlhagen G, Takimoto C, Robey R, Pommier Y, Fojo T, Bates SE. Brangi M, et al. Cancer Res. 1999 Dec 1;59(23):5938-46. Cancer Res. 1999. PMID: 10606239

4

Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXR.

de Bruin M, Miyake K, Litman T, Robey R, Bates SE. de Bruin M, et al. Cancer Lett. 1999 Nov 15;146(2):117-26. doi: 10.1016/s0304-3835(99)00182-2. Cancer Lett. 1999. PMID: 10656616

5

Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells.

Robey RW, Medina-Pérez WY, Nishiyama K, Lahusen T, Miyake K, Litman T, Senderowicz AM, Ross DD, Bates SE. Robey RW, et al. Clin Cancer Res. 2001 Jan;7(1):145-52. Clin Cancer Res. 2001. PMID: 11205902

6

Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells.

Honjo Y, Hrycyna CA, Yan QW, Medina-Pérez WY, Robey RW, van de Laar A, Litman T, Dean M, Bates SE. Honjo Y, et al. Among authors: robey rw. Cancer Res. 2001 Sep 15;61(18):6635-9. Cancer Res. 2001. PMID: 11559526

7

A Phase I study of infusional vinblastine in combination with the P-glycoprotein antagonist PSC 833 (valspodar).

Bates S, Kang M, Meadows B, Bakke S, Choyke P, Merino M, Goldspiel B, Chico I, Smith T, Chen C, Robey R, Bergan R, Figg WD, Fojo T. Bates S, et al. Cancer. 2001 Sep 15;92(6):1577-90. doi: 10.1002/1097-0142(20010915)92:6<1577::aid-cncr1484>3.0.co;2-h. Cancer. 2001. PMID: 11745237 Clinical Trial.

8

Reversal of multidrug resistance: lessons from clinical oncology.

Bates SF, Chen C, Robey R, Kang M, Figg WD, Fojo T. Bates SF, et al. Novartis Found Symp. 2002;243:83-96; discussion 96-102, 180-5. Novartis Found Symp. 2002. PMID: 11990784 Review.

9

A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist.

Abraham J, Bakke S, Rutt A, Meadows B, Merino M, Alexander R, Schrump D, Bartlett D, Choyke P, Robey R, Hung E, Steinberg SM, Bates S, Fojo T. Abraham J, et al. Cancer. 2002 May 1;94(9):2333-43. doi: 10.1002/cncr.10487. Cancer. 2002. PMID: 12015757 Free article.

10

Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance.

Volk EL, Farley KM, Wu Y, Li F, Robey RW, Schneider E. Volk EL, et al. Among authors: robey rw. Cancer Res. 2002 Sep 1;62(17):5035-40. Cancer Res. 2002. PMID: 12208758

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

161 results

Search Page

Filters